CPIX FY2025 SEC EDGAR DEF 14A #140 of 168 in industry

Cumberland Pharmaceuticals Inc CEO pay ratio

The CEO earned $101K in FY2025 against median worker pay of $101,000 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
TN
Filing date
2026-03-09
Industry
Chemicals & Pharmaceuticals
Industry rank
#140/168

Data updated August 2026

Subscribe to Cumberland Pharmaceuticals Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
10:1
Below Average (Scale: 0–1000:1)
CEO pay
$101K
Median worker
$101,000

Answer first

Cumberland Pharmaceuticals Inc's FY2025 CEO total of $101K ranks #1413 of 1,423 complete filings; its 10:1 pay ratio ranks #1275. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $101,000. Industry placement uses the FY2025 SIC-28 peer cohort (# 140 of 168, 17th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1413
$101K of 1,423 FY2025
Ratio rank
#1275
10:1 of 1,423
Industry pct
17th
among the lower quartile of industry peers by pay ratio

How Cumberland Pharmaceuticals Inc ranks nationally

Cumberland Pharmaceuticals Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$101,000 1st percentile higher than 1% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Cumberland Pharmaceuticals Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($101K) against pay ratio (10:1) for Cumberland Pharmaceuticals Inc (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02072365.44144730.96217096.38289461.87.3:116.4:125.5:134.6:143.6:1CEO total payPay ratio (CEO : median worker)Cumberland Pharmaceuticals Inc, CEO total pay: 101000 · Pay ratio (CEO : median worker): 10:1Cumberland Pharmaceuticals IncAcadia Pharmaceuticals Inc, CEO total pay: 2574405 · Pay ratio (CEO : median worker): 9:1Acadia Pharmaceuticals IncPuma Biotechnology, Inc., CEO total pay: 3062337 · Pay ratio (CEO : median worker): 11:1Puma Biotechnology, Inc.Amylyx Pharmaceuticals, Inc., CEO total pay: 2685240 · Pay ratio (CEO : median worker): 9:1Amylyx Pharmaceuticals, Inc.Arcus Biosciences, Inc., CEO total pay: 2423421 · Pay ratio (CEO : median worker): 9:1Arcus Biosciences, Inc.Lifecore Biomedical, Inc. \de\, CEO total pay: 6547620 · Pay ratio (CEO : median worker): 12:1Lifecore Biomedical, Inc. \de\
Cumberland Pharmaceuticals Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Cumberland Pharmaceuticals Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Cumberland Pharmaceuticals Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2024–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
10:1
FY2025
vs prior FY
-2:1
from FY2024 12:1
CEO $ YoY
-92%
$101K latest
Filings shown
2
FY2024–2025
Cumberland Pharmaceuticals Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2024 $1.2M - $99,665 12:1 -
2025 $101K -92% $101,000 10:1 -2:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1087294, FY2024–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
10:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$101K
Companies in Industry
168
vs. Industry Median
Below
#140 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Cumberland Pharmaceuticals Inc: near-parity Item 402(u) ratio

Cumberland Pharmaceuticals Inc's FY2025 ratio 10:1 ranks #140 of 168 Chemicals & Pharmaceuticals filers (17th percentile). the CEO earned 10× the median employee ($101,000) in FY2025.

At $101,000 median worker pay, the FLOOR stamp is near pay-parity territory under MICRO CEO total.

CEO Total Pay

$101K

FY2025 Summary Compensation, below median

Pay Ratio

10:1

Below typical

Cumberland Pharmaceuticals Inc in the lower Chemicals & Pharmaceuticals third

Cumberland Pharmaceuticals Inc's FY2025 ratio 10:1 ranks #140 of 168 Chemicals & Pharmaceuticals filers (17th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Cumberland Pharmaceuticals Inc's $101K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1413 and ratio rank #1275 split - treat 10:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$101K
Median Employee Pay
$101,000
Pay Ratio
10:1
Filing Date
2026-03-09

Company Info

Ticker
CPIX
CIK
1087294
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
TN
View SEC filings →
SEC EDGAR DEF 14A for CIK 1087294, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Cumberland Pharmaceuticals Inc's FY2025 ratio 10:1 ranks #140 of 168 Chemicals & Pharmaceuticals filers (17th percentile).

Read with Cumberland Pharmaceuticals Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MICRO · HIGH-MED.

Insperity, Inc. · MICRO

ABS(ceo_total_comp) peer at $101K (Δ $318 heavier vs Cumberland Pharmaceuticals Inc); STEEP · HIGH-MED vs this page's FLOOR · MICRO · HIGH-MED.
Universal Safety Products, Inc. · MICRO

ABS(ceo_total_comp) peer at $100K (Δ $533 lighter vs Cumberland Pharmaceuticals Inc); MODEST · HIGH-MED vs this page's FLOOR · MICRO · HIGH-MED.
Argan Inc · MICRO

ABS(ceo_total_comp) peer at $100K (Δ $632 lighter vs Cumberland Pharmaceuticals Inc); MODEST · HIGH-MED vs this page's FLOOR · MICRO · HIGH-MED.
Clearwater Paper Corp · MICRO

ABS(ceo_total_comp) peer at $102K (Δ $674 heavier vs Cumberland Pharmaceuticals Inc); MODEST · HIGH-MED vs this page's FLOOR · MICRO · HIGH-MED.
Acadia Pharmaceuticals Inc (SIC 28 pole)

Acadia Pharmaceuticals Inc stamps FLOOR · MID$ nearest in-SIC by ABS(pay_ratio) to Cumberland Pharmaceuticals Inc's FLOOR filing.
National dual ranks · #1413/#1275

Cumberland Pharmaceuticals Inc's FY2025 package sits #1413 by CEO dollars and #1275 by ratio under MICRO · FLOOR.
Ratio primer · FLOOR

Cumberland Pharmaceuticals Inc's FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Cumberland Pharmaceuticals Inc (CIK 1087294), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.